Research priorities towards precision antibiotic therapy to improve patient care
Research priorities towards precision antibiotic therapy to improve patient care
Z.P. Bulman, S.G. Wicha, E.I. Nielsen, J.R. Lenhard, R.L. Nation, U. Theuretzbacher, H. Derendorf, T. Tängdén, M. Zeitlinger, C.B. Landersdorfer, J.B. Bulitta, L.E. Friberg, J. Li, B. Tsuji
The Lancet Microbe, ahaed of print (2022).
Please login to see attachment
From Therapeutic Drug Monitoring to Model-Informed Precision Dosing for Antibiotics
From Therapeutic Drug Monitoring to Model-Informed Precision Dosing for Antibiotics
SG Wicha, A.G. Märtson, E.I. Nielsen, B.C.P. Koch, L.E. Friberg, J.W. Alffenaar, I.K. Minichmayr
Clinical Pharmacology & Therapeutics, 109, 928-941 (2021).
Please login to see attachment
International Consensus Guidelines for the Optimal Use of the Polymyxins.
BT Tsuji, JM Pegue, AP Zavascki, M Paul, GL Daikos, A Forrest, DR Giacobbe, C Viscoli, H Giamarellou, I Karaiskos, D Kaye, JW Mouton, VH Tam, C Thamlikitkul, RG Wunderink, J Li, RL Nation, KS Kaye
Pharmacotherapy, 39, 10-39 (2019).
Please login to see attachment
Concentration-dependent plasma protein binding: Expect the unexpected
Concentration-dependent plasma protein binding: Expect the unexpected
RL Nation, U Theuretzbacher, BT Tsuji, on behalf of the International Society of Anti-Infective Pharmacology (ISAP)
European Journal of Pharmaceutical Sciences, 122, 341-346 (2018).
Please login to see attachment
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus: RL Nation, J Li, O. Cars, W. Couet, MN Dudley, KS Kaye, JW Mouton, DL Paterson, VH Tam, U. Theuretzbacher, BT Tsuji, JD Turnidge.
The Lancet Infectious Diseases, Early Online Publication, 21 October 2014
Please login to see attachment
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
Jason A Roberts, Mohd H Abdul-Aziz, Jeff rey Lipman, Johan W Mouton, Alexander A Vinks, Timothy W Felton, William W Hope, Andras Farkas, Michael N Neely, Jerome J Schentag, George Drusano, Otto R Frey, Ursula Theuretzbacher, Joseph L Kuti, on behalf of The International Society of Anti-Infective Pharmacology and the Pharmacokinetics and Pharmacodynamics Study Group of the European Society of Clinical Microbiology and Infectious Diseases
Lancet Infect Dis April 2014
Please login to see attachment
Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents
Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents.
Gonzalez D, Schmidt S, Derendorf H.
Clin Microbiol Rev. 2013 Apr;26(2):274-88.
Please login to see attachment
New EMA guideline for antimicrobial development
New EMA guideline for antimicrobial development.
Ambrose PG, Bhavnani SM, Dudley MN, Ellis-Grosse E, Rubino CM, Drusano GL.
Lancet Infect Dis. 2012 Apr;12(4):265-6.
Please login to see attachment
Saving Lives with Optimal Antimicrobial Chemotherapy
Saving Lives with Optimal Antimicrobial Chemotherapy
Drusano GL, Lodise TP
Clin Infect Dis 2012 Oct 16
Please login to see attachment
Predicting bacterial fitness cost associated with drug resistance
Predicting bacterial fitness cost associated with drug resistance.
Guo B, Abdelraouf K, Ledesma KR, Nikolaou M, Tam VH.
J Antimicrob Chemother. 2012 Apr;67(4):928-32.